Business Description
Celcuity is a Minneapolis-based clinical-stage company founded in 2011 that develops precision treatments for solid tumors. Its primary focus is Gedatolisib, a drug designed to block key molecular pathways that drive advanced breast cancer and metastatic prostate cancer. The company holds a licensing agreement with Pfizer covering the development and commercialization of this drug candidate.
